Non-Cytologic Cervical Screening Is Cost-Effective – NEJM Study
This article was originally published in The Gray Sheet
Executive Summary
Strategies such as visual inspection of the cervix or the use of human papillomavirus assays that require only one or two clinical visits are cost-effective alternatives to conventional three-visit cytology-based screening in low-resource settings, according to a study published in the Nov. 17 New England Journal of Medicine